Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Kalaris Therapeutics Inc Q2 Operating Income USD -12.386 Million Vs. IBES Estimate USD -12.5 Million

BRIEF-Kalaris Therapeutics Inc Q2 Operating Income USD -12.386 Million Vs. IBES Estimate USD -12.5 Million

ReutersReuters2026/08/11 12:01
By:Reuters

Aug 11 (Reuters) - Kalaris Therapeutics Inc Q2 operating expenses USD 12.386 million.

  • Q2 net income USD -11.515 million vs. IBES estimate USD -12.1 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!